Cathy Klema Optimize Rx Corp (OPRX) insider trading activity

OPRX Quotes by TradingView

Cathy Klema is Director of OptimizeRx Corp. Currently has a direct ownership of 21,620 shares of OPRX, which is worth approximately $282,141. The most recent transaction as insider was on Jun 11, 2025, when has been sold 9,868 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.6K
83.97% 3M change
225.46% 12M change
Total Value Held $282,141

CATHY KLEMA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2025
BUY
Grant, award, or other acquisition
-
9,868 Added 31.34%
21,620 Common Stock
Feb 02 2025
BUY
Exercise of conversion of derivative security
-
5,109 Added 30.3%
11,752 Common Stock
Jun 07 2024
BUY
Grant, award, or other acquisition
-
6,643 Added 50.0%
6,643 Common Stock
CK

Cathy Klema

Director
Waltham, MA

Track Institutional and Insider Activities on OPRX

Follow OptimizeRx Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPRX shares.

Notify only if

Insider Trading

Get notified when an Optimize Rx Corp insider buys or sells OPRX shares.

Notify only if

News

Receive news related to OptimizeRx Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OPRX